T. Rowe Price Associates’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-599,300	Closed	-$5.68M	–	2549
2013 Q3	$5.68M	Hold	599,300	–	–	﹤0.01%	1400
2013 Q2	$5.68M	Buy	+599,300	New	+$5.68M	﹤0.01%	1382